It is now under investigation on its
efficacy for the treatment of Duchenne muscular dystrophy, Leber's hereditary optic neuropathy,
mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes as well as primary progressive multiple sclerosis.